Fixed Combinations for Reducing RAS Activity in Nephrological Practice

Authors

  • D.D. Ivanov

DOI:

https://doi.org/10.22141/2307-1257.0.2.2012.176619

Abstract

No abstract

Downloads

Download data is not yet available.

References

Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease // Kidney inter., Suppl. — 2012. — 2. — 337-414. http://www.kidney-international.org & 2012 KDIGO 340

National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update // Am. J. Kidney Dis. — 2012. — 60 (5). — 850-886.

http://www.druglib.com/druginfo/tarka/

Ruggenenti P. et al. Role of remission clinics in the longitudinal treatment of CKD // J. Am. Soc. Nephrol. — 2008. — 19. — 1213-1224.

http://www.druglib.com/druginfo/exforgehct/description_phar­macology/

Ruggenenti P., Lauria G., Iliev I.P. et al. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial // Hypertension. — 2011 Nov. — 58 (5). — 776-83. Epub 2011 Sep 19.

Ortiz M., Calcino G. Inferred mortality differences between dihydropyridine antihypertensives // Hypertension. — 2009. — 53. — 1116.

Borghi C., Cicero A.F. Rationale for the use of fixed-dose combination in the management of hypertension: efficacy and tolerability of lercandipine/enalapril // Clin. Drug Investig. — 2010. — 30 (12). — 843-854.

Rump C. Efficacy and tolerability of the fixed lercanidipine enalapril combination in the treatment of patients with essential hypertension // Arzneimittelforschung. — 2010. — 60 (3). — 124-130.

Scholze J., Bramlage P., Trenkwalder P., Kreutz R. Эффективность и безопасность применения фиксированного сочетания лерканидипина и эналаприла в повседневной практике. Сравнение «офисного», амбулаторного и самостоятельно измеряемого артериального давления // Лікарю-практику. — 2012. — № 3. — С. 1-8.

Quarti F., Seravalle G., Dell Oro R., Magni L., Muraro S., Mancia G., Grassi G. Effects of lercanidipine/enelapril combination on neurometabolic alterations in obese hypertensive subjects // High blood pressure Cardiovasc Prev. — 2010. — 17 (3). — 1120.

Egan C.G., Pontremoli R. Role of the fixed combination lercanidipine-enelapril in renal protection // J. Nephrol. — 2011. — 24. — 428-37.

Downloads

Published

2022-02-15

How to Cite

Ivanov, D. (2022). Fixed Combinations for Reducing RAS Activity in Nephrological Practice. KIDNEYS, (2), 47–49. https://doi.org/10.22141/2307-1257.0.2.2012.176619

Issue

No. 2 (2012)

Section

Pharmacology Workshop

License

Copyright (c) 2012 D.D. Ivanov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.